NCT04556773 2025-12-17
DB-08
AstraZeneca
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT02648477 2024-03-19
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 2 Completed
NCT01234532 2022-05-03
0927GCC
University of Maryland, Baltimore
Phase 2 Terminated
NCT02089854 2016-12-02
AETNBC
Peking Union Medical College Hospital
Phase 4 Unknown